Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET
Company Participants
Carolyne Sohn – Investor Relations
Brandon Sim – Co-Chief Executive Officer
Chan Basho – Chief Strategy Officer and Interim Chief Financial Officer
Conference Call Participants
Operator
Good day. And welcome to your Apollo Medical Holdings’ Second Quarter 2022 Financial Results Call. [Operator Instructions]
At this time, I'll turn the conference over to Carolyne Sohn of The Equity Group. The floor is yours, please go ahead.
Carolyne Sohn
Thank you, operator, and hello, everyone. Thank you for joining us.
The press release announcing Apollo Medical Holdings, Inc.'s results for the second quarter ended June 30, 2022, is available at the Investors section of the company's website at www.apollomed.net.
To provide some additional background on its results, the company has made a supplemental deck available on its website.
A replay of this broadcast will also be made available at ApolloMed's website after the conclusion of this call.
Before we get started, I would like to remind everyone that this conference call and any accompanying information discussed herein contains certain forward-looking statements within the meaning of the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terms such as anticipate, believe, expect, future, plan, outlook and will and include, among other things, statements regarding the company's guidance for the year ending December 31, 2022, continued growth, acquisition strategy, ability to deliver sustainable long-term value, ability to respond to the changing environment, operational focus, strategic growth plans and merger integration efforts as well as the impact of the 2020 novel coronavirus or COVID-19 pandemic and other variants on the company's business, operations and financial results.
Although the company believes that the expectations reflected in its forward-looking statements are reasonable as of today, those statements are subject to risks and uncertainties that could cause the actual results to differ dramatically from those projected. There can be no assurance that those expectations will prove to be correct. Information about the risks associated with investing in ApolloMed is included in its filings with the Securities and Exchange Commission, which we encourage you to review before making an investment decision.
The company does not assume any obligation to update any forward-looking statements as a result of new information, future events, changes in market conditions or otherwise, except as required by law.